ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)

CUSIP: 682310875

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock, no par value
Shares outstanding
109,272,143
Total 13F shares
903,524
Share change
+316
Total reported value
$1,890,946
Price per share
$2.09
Number of holders
32
Value change
-$125,314
Number of buys
10
Number of sells
13

Security key

682310875

Report period

Q3 2021

Institutions

32

Top holders

10

Top shareholders of ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC
13F
Company
0.15%
161,826
$448,000 30 Jun 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.14%
150,673
$919,000 30 Jun 2021
13F
Advisor Resource Council
13F
Company
0.09%
101,000
$280,000 30 Jun 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.08%
91,000
$252,000 30 Jun 2021
13F
CIBC WORLD MARKET INC.
13F
Company
0.06%
61,940
$172,000 30 Jun 2021
13F
TD ASSET MANAGEMENT INC
13F
Company
0.05%
52,007
$120,000 30 Jun 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.05%
49,310
$137,000 30 Jun 2021
13F
MORGAN STANLEY
13F
Company
0.04%
46,278
$128,000 30 Jun 2021
13F
ROYAL BANK OF CANADA
13F
Company
0.03%
36,652
$102,000 30 Jun 2021
13F
Virtu Financial LLC
13F
Company
0.03%
35,425
$98,000 30 Jun 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.03%
29,389
$81,000 30 Jun 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.02%
25,200
$70,000 30 Jun 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.02%
24,545
$67,000 30 Jun 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.02%
23,000
$64,000 30 Jun 2021
13F
UBS Group AG
13F
Company
0.02%
20,537
$57,000 30 Jun 2021
13F
BRAVE ASSET MANAGEMENT INC
13F
Company
0.02%
20,000
$55,000 30 Jun 2021
13F
BANK OF MONTREAL /CAN/
13F
Company
0.02%
16,460
$46,000 30 Jun 2021
13F
COMERICA BANK
13F
Company
0.01%
15,526
$32,000 30 Jun 2021
13F
LPL Financial LLC
13F
Company
0.01%
11,960
$33,000 30 Jun 2021
13F
Cantonale Vaudoise Banque
13F
Individual
0.01%
11,268
$31,000 30 Jun 2021
13F
CHIRON CAPITAL MANAGEMENT, LLC
13F
Company
0.01%
10,200
$28,000 30 Jun 2021
13F
Crescent Grove Advisors, LLC
13F
Company
0.01%
10,000
$28,000 30 Jun 2021
13F
Cedar Mountain Advisors, LLC
13F
Company
0.01%
5,651
$16,000 30 Jun 2021
13F
Rockefeller Capital Management L.P.
13F
Company
0.01%
5,540
$15,000 30 Jun 2021
13F
Disciplined Investments, LLC
13F
Company
0%
5,189
$14,000 30 Jun 2021
13F
IFP Advisors, Inc
13F
Company
0%
5,000
$14,000 30 Jun 2021
13F
TRUST CO OF VERMONT
13F
Company
0%
5,000
$14,000 30 Jun 2021
13F
Zions Bancorporation, N.A.
13F
Company
0%
5,000
$14,000 30 Jun 2021
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
4,462
$12,000 30 Jun 2021
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0%
3,407
$9,336 30 Jun 2021
13F
TORONTO DOMINION BANK
13F
Company
0%
2,600
$7,000 30 Jun 2021
13F
HARBOUR INVESTMENTS, INC.
13F
Company
0%
2,330
$6,000 30 Jun 2021
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
2,160
$6,000 30 Jun 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
1,500
$4,000 30 Jun 2021
13F
FIFTH THIRD BANCORP
13F
Company
0%
1,000
$3,000 30 Jun 2021
13F
SITTNER & NELSON, LLC
13F
Company
0%
1,000
$3,000 30 Jun 2021
13F
Red Door Wealth Management, LLC
13F
Company
0%
1,000
$2,000 30 Jun 2021
13F
NEXT Financial Group, Inc
13F
Company
0%
946
$3,000 30 Jun 2021
13F
JNBA Financial Advisors
13F
Company
0%
210
$1,000 30 Jun 2021
13F

Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q3 2021

As of 30 Sep 2021, ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 903,524 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, MORGAN STANLEY, CIBC World Markets Inc., ROYAL BANK OF CANADA, TWO SIGMA ADVISERS, LP, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, BANK OF AMERICA CORP /DE/, and UBS Group AG. This page lists 32 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
35
Q3 2021 holders
32
Holder diff
-3
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 Value $ Q3 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .